Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

TYMS antibody (AA 60-174)

The Mouse Monoclonal anti-TYMS antibody is suitable to detect TYMS in samples from Human. It has been validated for WB, IF, FACS and IHC (p).
Catalog No. ABIN5646952
$640.46
Plus shipping costs $50.00
Shipping to: United States
Delivery in 2 to 4 Business Days

Quick Overview for TYMS antibody (AA 60-174) (ABIN5646952)

Target

See all TYMS Antibodies
TYMS (Thymidylate Synthetase (TYMS))

Reactivity

  • 144
  • 40
  • 27
  • 4
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
Human

Host

  • 73
  • 70
  • 1
Mouse

Clonality

  • 97
  • 47
Monoclonal

Conjugate

  • 71
  • 10
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This TYMS antibody is un-conjugated

Application

  • 77
  • 74
  • 71
  • 49
  • 26
  • 25
  • 19
  • 18
  • 17
  • 15
  • 14
  • 13
  • 12
  • 4
  • 3
  • 3
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB), Immunofluorescence (IF), Flow Cytometry (FACS), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Clone

TYMS-1884
  • Binding Specificity

    • 30
    • 15
    • 15
    • 5
    • 4
    • 4
    • 4
    • 4
    • 3
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 60-174

    Purpose

    TYMS Antibody / Thymidylate Synthase

    Characteristics

    This antibody recognizes a protein of 36 kDa, identified as Thymidylate Synthase (TS, TYMS). TS converts deoxyuridine monophosphate (dUMP) to deoxythymidine monophosphate (dTMP), which is essential for DNA biosynthesis. TS is also a critical target for the fluoropyrimidines, an important group of antineoplastic drugs that are widely used in the treatment of solid tumors. Both 5-FU and fluorodeoxyuridine are converted in tumor cells to FdUMP which inactivates TS by formation of a ternary covalent complex in the presence of the folate cofactor 5,10-methylenetetrahydrofolate. Expression of TS protein is associated with response to 5-fluorouracil (5-FU) in human colorectal, gastric, head and neck, and breast carcinomas.

    Purification

    Protein G affinity chromatography

    Immunogen

    A recombinant human parital protein corresponding to amino acids 60-174 was used as the immunogen for this TYMS antibody.

    Isotype

    IgG2c, kappa
  • Application Notes

    The optimal dilution of the TYMS antibody for each application should be determined by the researcher.

    1. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    0.2 mg/mL

    Buffer

    0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced) and 0.05 % sodium azide

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    4 °C,-20 °C

    Storage Comment

    Store the TYMS antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
  • Target

    TYMS (Thymidylate Synthetase (TYMS))

    Alternative Name

    TYMS

    Background

    This antibody recognizes a protein of 36 kDa, identified as Thymidylate Synthase (TS, TYMS). TS converts deoxyuridine monophosphate (dUMP) to deoxythymidine monophosphate (dTMP), which is essential for DNA biosynthesis. TS is also a critical target for the fluoropyrimidines, an important group of antineoplastic drugs that are widely used in the treatment of solid tumors. Both 5-FU and fluorodeoxyuridine are converted in tumor cells to FdUMP which inactivates TS by formation of a ternary covalent complex in the presence of the folate cofactor 5,10-methylenetetrahydrofolate. Expression of TS protein is associated with response to 5-fluorouracil (5-FU) in human colorectal, gastric, head and neck, and breast carcinomas.

    UniProt

    P04818

    Pathways

    Mitotic G1-G1/S Phases
You are here:
Chat with us!